DIFFERIN EPIDUO FDA approval date

The FDA approved DIFFERIN EPIDUO on 22 May 2026.

FDA approval date
22 May 2026

Drug identity has not yet been verified against registry records

Also recorded as ADAPALENE; BENZOYL PEROXIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-05-22DayDIFFERIN EPIDUOFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA220736", "applicant_as_listed_by_fda": "GALDERMA LABS LP", "brand_names": ["DIFFERIN EPIDUO", "DIFFERIN EPIDUO ACNE GEL (ADAPALENE AND BENZOYL PEROXIDE)"], "active_ingredients": ["ADAPALENE", "ADAPALENE, BENZOYL PEROXIDE", "BENZOYL PEROXIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260522", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026